Human Study: Other Committee Approvals
Some research protocol components will require review and approval by additional committees at UT Health SA or other institutions.
| When the study involves | Committee approval required | Learn more |
|---|---|---|
| Identifible data or a limited data set collected under a HIPAA waiver and will be released to an outside entity |
Patient Data Governance Committee |
|
|
A researcher who has a conflict of interest (COI) related to the research |
Conflict of Interest Committee (COIC) If needed, a COI Management Plan is created by the COIC and forwarded to the the designated IRB for final approval. |
|
|
Biologic hazards, microbiologic or viral agents, pathogens, cell lines, non-FDA approved vaccines, recombinant DNA, or human gene therapy |
Institutional Biosafety Committee (IBC) |
|
|
Radiation exposure, radioactive materials, or radiation generating equipment |
Radiation Safety Committee (RSC) |
|
|
Radioactive drugs or agents unless the drug falls under an Investigational New Drug (IND) or New Drug Approval (NDA) FDA |
Radioactive Drug Research Committee (RDRC) |
|
|
Cancer related research irrespective of funding source |
Mays Cancer Center's Protocol Review Committee (PRC) |
|
|
Involves Child Protective Services |
Texas Department of Family and Protective Services (DFPS) |
Learn more about Texas Department of Family and Protective Services |
|
Research activities being conducted at Veteran's Administration facilities |
VA - South Texas Veterans Health Care System Research and Development Committee |
|
| Research activities being conducted at University Health | University Health Research Committee | Learn more about the UHS submission process |
The Institutional Biosafety Committee, Radiation Safety Committee and the Radioactive Drug Research Committee are supported by the Environmental Health and Safety Department. Learn more about Environmental Health and Safety Department